Motus GI Holdings, Inc. (MOTS) Research
Motus GI Holdings, Inc. operates as a medical technology enterprise within the United States. The company's core innovation is the Pure-Vu system, a specialized medical instrument designed to enhance the cleansing of an inadequately prepared gastrointestinal tract during colonoscopy procedures, while also streamlining upper gastrointestinal endoscopies. Formerly known as Eight-Ten Merger Corp., the organization adopted its present name, Motus GI Holdings, Inc., in November 2016. This entity was established in 2008 and maintains its headquarters in Fort Lauderdale, Florida.
Market snapshot
- Symbol
- MOTS
- Price
- $0.00
- Day change
- 0.00%
- Market cap
- $639.0
- P/E ratio
- -0.00x
- 52-week range
- 0.00001-0.1
- Sector
- Healthcare
- Industry
- Medical - Devices
- Next earnings
- in 2 months
Peer companies
Recent insider activity
- Durbin Scott — A-Award (23205 shares) on 2024-03-05
- Nelson Sonja — A-Award (23205 shares) on 2024-03-05
- Pruden Gary J — A-Award (23205 shares) on 2024-03-05
- Moran Timothy P. — A-Award (23205 shares) on 2024-03-05
- Orchestra BioMed Holdings, Inc. — trade (0 shares) on 2023-09-12
Open Motus GI Holdings, Inc. (MOTS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.